Neurology News

In a company press release, Blackrock Neurotech announced the acquisition of spatial computing software firm MindX to bolster its development of technologically advanced brain-computer interface products.

The FDA has approved Neuronetics’ transcranial magnetic stimulation system, called NeuroStar, as an adjunct treatment for adults with obsessive compulsive disorder.

U.S. death data show the burden of ischemic heart disease, cerebrovascular disease and HF deaths vary significantly across Asian American subgroups, emphasizing the importance of tailoring CVD prevention and management strategies.

Alzamend Neuro Inc. has announced the launch of a phase 2A trial for its AL001 treatment for mild to moderate Alzheimer’s dementia.

The Indian Health Service has announced it will allocate $5 million in funding toward resources to address Alzheimer’s disease among tribal communities.

In-hospital outcomes for acute ischemic stroke patients with solid organ malignancy varied depending on the type of cancer and use of stroke interventions, according to a study published in Neurology.

Epilepsy was not a significant factor among adults who had been hospitalized for attempted suicide, according to a study published in the Journal of Clinical Psychiatry.

Digital therapeutics company Big Health has announced a partnership with the University of Oxford for a new study evaluating Sleepio, an online program designed to improve sleep and mental health for stroke patients.

PHILADELPHIA — Diffuse axonal injury-type lesions in postoperative MRI can predict poor outcomes for children with severe traumatic brain injury, a presenter said at the American Association of Neurological Surgeons annual meeting.

Patients with Lennox-Gastaut syndrome experienced a significant reduction in drop seizures with fenfluramine, according to results of a clinical trial published in JAMA Neurology.